Enanta Pharmaceuticals Inc (ENTA) — Cash Flow Quality Index
Enanta Pharmaceuticals Inc (ENTA) has a Cash Flow Quality Index of 0.92x as of December 2019. Operating cash flow of $12.36 Million is below net income of $13.44 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Enanta Pharmaceuticals Inc (ENTA) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Enanta Pharmaceuticals Inc Cash Flow Quality Index (2010–2019)
Historical Cash Flow Quality Index for Enanta Pharmaceuticals Inc across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Enanta Pharmaceuticals Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Enanta Pharmaceuticals Inc (2010–2019)
Year-by-year earnings quality comparison for Enanta Pharmaceuticals Inc. For live market cap and the full company financial profile, see ENTA market cap.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | 1.54x | $71.42 Million | $46.38 Million | ▲ +279.2% |
| 2018 | 0.41x | $29.22 Million | $71.96 Million | ▼ -86.3% |
| 2017 | 2.97x | $52.65 Million | $17.71 Million | ▲ +79.9% |
| 2016 | 1.65x | $35.81 Million | $21.67 Million | ▲ +70.3% |
| 2015 | 0.97x | $76.67 Million | $78.99 Million | ▲ +65.7% |
| 2014 | 0.59x | $20.18 Million | $34.44 Million | ▼ -47.0% |
| 2013 | 1.11x | $10.65 Million | $9.63 Million | ▲ +4.7% |
| 2012 | 1.06x | $22.62 Million | $21.40 Million | ▲ +2.6% |
| 2011 | 1.03x | $24.02 Million | $23.31 Million | ▲ +180.0% |
| 2010 | -1.29x | $-10.18 Million | $7.90 Million | — |